In Brief: TAP Prevacid
Executive Summary
TAP Prevacid: New indication for the short-term treatment of symptomatic gastroesophogeal reflex disease approved March 12. The lansoprazole sNDA (20-406/S-016) was submitted Oct. 31, 1997 and had a user fee goal of Sept. 10...